Bone marrow transplantation is the definitive treatment of severe aplastic anemia; however, with the absence of this option, combined immunosuppressive therapy with antithymocyte globulin (ATG) and cyclosporine A is used as a first-line therapy. This case report highlights the possible delay in response to ATG protocol in treating aplastic anemia.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986045 | PMC |
| http://dx.doi.org/10.1002/ccr3.1517 | DOI Listing |
Publication Analysis
Top Keywords
aplastic anemia
12
severe aplastic
8
immunosuppressive therapy
8
therapy case
8
case report
8
idiopathic severe
4
anemia delayed
4
delayed response
4
response immunosuppressive
4
report bone
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!